Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumors Malignancies

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumors Malignancies
Conditions:   Advanced Solid Tumor;   Urinary Bladder Neoplasm;   Pancreatic Neoplasms;   Triple Negative Breast Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Stomach Neoplasm;   Esophageal Neoplasms;   Ovarian Neoplasm
Interventions:   Drug: BT8009;   Drug: Nivolumab
Sponsor:   Bicycle Tx Limited
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 24, 2020 / by / in
Comments